SanBio, Inc. Announces Enrollment of the Second Cohort of Patients in Its Clinical Trial of Stem Cell Therapy for Chronic Stroke
1/14/2013 9:57:30 AM
More...
|
SanBio, Inc. Announces Enrollment of First Cohort of Patients in Its Clinical Trial of Stem Cell Therapy for Chronic Stroke
3/20/2012 10:23:16 AM
More...
|
SanBio, Inc. Announces First Patient Treated at Stanford With Novel Cell Therapy, SB623, in Clinical Trial of Stable Stroke Patients
9/28/2011 10:42:26 AM
More...
|
SanBio, Inc. Announces Site Opening of Phase 1/2a Clinical Trial of Novel Cell Therapy in Stable Stroke Patients at University of Pittsburgh Medical Center
9/20/2011 11:23:34 AM
More...
|
Stanford University and SanBio, Inc. Announce a Clinical Trial of Cell Therapy for Stroke Disability
4/21/2011 7:50:13 AM
More...
|
Dainippon Sumitomo Pharma Co., Ltd. and SanBio, Inc. Collaborate on Cell Therapy for Stroke Recovery
10/4/2010 12:03:50 PM
More...
|
SanBio, Inc. Receives FDA Clearance to Initiate Cell Therapy Clinical Studies for Stroke Recovery
6/17/2010 9:44:06 AM
More...
|
Tm Bioscience Corporation (CV:TMC) Signs Distribution Agreement With SanBio, Inc. To Commercialize The ID-Tag(TM) Respiratory Viral Panel In The Netherlands
6/16/2006 5:21:51 PM
More...
|